Background and Objectives To avoid “chemical restraints,” policies and guidelines have been
implemented to curb the use of medications for behavioral and psychological symptoms of …

Background: Guidelines, policies, and warnings have been applied to reduce the use of
medications for behavioral and psychological symptoms of dementia (BPSD). Because of rare …

Objective: Over the two years following the 2012 introduction of CMS’s National Partnership,
combined rates of schizophrenia, Tourette’s, and Huntington’s in US long-stay residents …

We used the sex ratio of neonate Daphnia, as well as the more standard endpoints of adult
survivorship and fecundity and neonatal morphology, as an assay for detecting the effects of …

Background Extensive investigation has established that an elevated weight at birth is
associated with subsequent obesity and obesity related negative health outcomes. The …

Objectives Compare Virginia nursing homes in the top- and bottom-quintiles of antipsychotic
use for variation in community, social, and facility factors. Methods 2018 CMS data …

Objective Excluded from reporting to CMS's Percentage of long-stay residents who got an
antipsychotic medication quality-measure are antipsychotics prescribed to nursing home …

Objectives: Evaluate current prevalence and changes in prescribing of antiseizure medications
(ASMs) in Virginia nursing homes for residents with and without seizures. Methods: …

Abstract. This retrospective cohort analysis of claims data used logistic regression to evaluate
change in antipsychotic and antiepileptic mood stabilizer prescription frequencies in …

Purpose The US Food and Drug Administration issued a boxed warning on all products
containing a long-acting β-agonist (LABA) in March 2006, after the findings from a trial …